KemPharm News

4: Statement of changes in beneficial ownership of securities-Director Watton Corey Michael

Oct 16 16:48 ET

8-K: Current report

Sep 20 16:13 ET

10-Q: Q2 2024 Earnings Report

Aug 14 14:30 ET

8-K: Zevra Therapeutics Reports Second Quarter 2024 Financial Results and Corporate Highlights

Aug 13 16:24 ET

8-K: Current report

Aug 9 17:08 ET

424B5: Prospectus

Aug 9 16:58 ET

8-K: Current report

Aug 8 16:18 ET

424B5: Prospectus

Aug 8 16:12 ET

8-K: Current report

Aug 5 14:07 ET

4: Statement of changes in beneficial ownership of securities-Officer Clifton R. LaDuane

Jul 17 17:57 ET

4: Statement of changes in beneficial ownership of securities-Director Anderson Thomas

Jul 16 16:43 ET

4: Statement of changes in beneficial ownership of securities-Director Bode John B

Jul 15 16:14 ET

8-K: Current report

Jul 12 16:42 ET

424B2: Prospectus

Jul 12 16:27 ET

8-K: Current report

Jul 9 09:25 ET

4: Statement of changes in beneficial ownership of securities-Officer Thompson Rahsaan

Jun 25 17:16 ET

3: Initial statement of beneficial ownership of securities-Officer Thompson Rahsaan

Jun 25 17:16 ET

EFFECT: Others

Jun 14 06:10 ET

CORRESP: CORRESP

Jun 10 13:58 ET

UPLOAD: Others

Jun 7 13:58 ET